−498
BridgeBio Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−419
FY23:
−528
FY24:
−521
FY25:
−446
Change from FY21 to FY25
millions USD
FY21:
−201
FY22:
453
FY23:
54.0
FY24:
60.8
FY25:
−24.5
Change from FY21 to FY25
millions USD
FY21:
736
FY22:
−13.1
FY23:
452
FY24:
748
FY25:
359
millions USD
FY21:
37.7
FY22:
20.5
FY23:
−22.2
FY24:
289
FY25:
−111
(positive)
Change from FY21 to FY25
millions USD
FY21:
−511
FY22:
−424
FY23:
−529
FY24:
−522
FY25:
−447
All amounts in millions USD